Skip to content

VETHERAPY

Active Private limited companyfounded 2011active for 15 yearsChaussée de Liège 19b, 4160 AnthisnesKBO/BCE: BE 0840.911.410 #5 company by total assets in Anthisnes, Professional and technical services sector

Lifetime

14 annual accounts with figures on one time axis
peak of €210,010 in 2015
€162,870▼ 18.7%
peak of €186,091 in 2024
€143,335▼ 23.0%
peak of €135,923 in 2016
€60,075▲ 11.8%
€556,368▲ 8.8%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
02-02-20262 days late
2025micro format
Gross margin from €200,334 to €162,870Company renamed from SPRL RENETTE – LIMBOURG to VETHERAPY 10-11

Key points

from the 2025 annual accounts

Equity

€60,075 from €135,923 in 2016

Equity fell by 56% in 9 years.

Debts

€556,368 90% of the balance sheet
Financial debts 3%Suppliers 61%Other 36%

Of this, €536,384 falls due within a year.

Position in the sector

9.7%

Lower solvency than 87% of companies in veterinary activities. The sector median is 52.3%, over 1,639 companies.

2025 accounts filed 2 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 537 companies had the same profile as VETHERAPY has now. Each dot stands for 2 companies, two years later.

95.9%
were still trading
3.4%
stopped another way
0.7%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 537 companies, not a prediction for VETHERAPY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 01-04-2018
Director, , since 24-05-2018
  • 50 sharesdeed of 22-11-2011
  • 50 sharesdeed of 22-11-2011
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0840911410
New establishment in Anthisnes Chaussée de Liège 19
Company renamed from SPRL RENETTE – LIMBOURG to VETHERAPY (director) and (director) reappointed · and act as permanent representatives · Registered office in the articles: Chaussée de Liège 19b, 4160 Anthisnes · Gazette deed
2 managers appointed, 2 resignations (manager) and (manager) resign · (manager) and . (manager) appointed · Discharge granted to (manager) · General meeting of 04-06-2018 · Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
VETHERAPY Anthisnes €616,443 €162,870 9.7% -
Dier en Tand Duffel €570,932 €162,212 92.5% -
PEVENAGE-VET Châtelet €653,123 €166,574 54.8% -
PIET VAN DE VOORDE Deinze €565,665 €145,212 71.7% -
dierenartsenpraktijk De Zaffelbeek Lochristi €647,757 €164,607 34.1% -
Dierenartsen-Kleidal Hemiksem €687,434 €177,795 67.9% -
Cabinet vétérinaire Cynthia Latteur La Louvière €693,969 €173,346 93.0% -

These companies have the same main activity as VETHERAPY: veterinary services (NACE 75000). They are comparable in size and age: total assets between €566,000 and €694,000, founded between 2010 and 2013.

Official details

Source: KBO
Status
Active since 09-11-2011Normal situation
Activity
Veterinary servicesNACE 75000
Establishment units
2.205.557.9874590 Ouffet, since 09-11-2011
2.384.326.8114160 Anthisnes, since 01-01-2026
Financial year end
30 June
Peppol
Reachable since 29-01-2026
Company details

Annual accounts to 30-06-2025

≈ €400,000estimated
€616,443▲ 9.1%
Filing
Filed on 02-02-2026
Financials

Insights on VETHERAPY

VETHERAPY files the micro format. That format states no turnover. The gross margin fell from €193,599 in 2012 to €162,870 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about VETHERAPY

What is the company number of VETHERAPY?
The company number of VETHERAPY is 0840.911.410. The VAT number is the same number with BE in front: BE 0840.911.410.
Where is VETHERAPY based?
The registered office is at Chaussée de Liège 19b, 4160 Anthisnes.Company details
What does VETHERAPY do?
According to the KBO register, the main activity is veterinary services (NACE 75000).
What is the legal form of VETHERAPY?
VETHERAPY is a private limited company (BV).
When was VETHERAPY founded?
VETHERAPY was founded on 09-11-2011.
Is VETHERAPY still active?
Yes, VETHERAPY is an active enterprise in the KBO register.
What is the turnover of VETHERAPY?
The turnover in financial year 2025 is about €400,000. This figure is estimated from the gross margin of €162,870 and 2,452 comparable companies of the same size. It probably lies between €270,000 and €630,000. It is a rough estimate.Financials
Is VETHERAPY profitable?
In financial year 2025, VETHERAPY made a profit of €143,335.
Where can I find the annual accounts of VETHERAPY?
VETHERAPY filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of VETHERAPY due?
VETHERAPY must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.